Literature DB >> 16546057

Current management of juvenile idiopathic arthritis.

Carol A Wallace1.   

Abstract

The goal of juvenile idiopathic arthritis (JIA) treatment is to achieve remission of disease. The absence of a full understanding of the disease pathogenesis for JIA hinders the development of truly effective treatment approaches. Further, the lack of clear knowledge regarding the mechanisms of action of rheumatologic medications and the existence of few randomized controlled trials leaves clinicians with very little evidence upon which to base decisions regarding the best timing, dosages or combinations of medications to be used for fully effective treatment of JIA. There is now a shift in treatment focus from that of chasing failure (gradual add-on approach to the use of medications) to one of early aggressive combination treatment. This chapter will discuss the current approaches to medical management of JIA and the medications currently available for use. JIA treatment is a vast, rich area in need of research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546057     DOI: 10.1016/j.berh.2005.11.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  13 in total

Review 1.  The humanistic and economic burden of juvenile idiopathic arthritis in the era of biologic medication.

Authors:  Wendy Gidman; Rachel Meacock; Deborah Symmons
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

2.  Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical study.

Authors:  Femke H M Prince; Marinka Twilt; Nelleke C J A Jansen-Wijngaarden; Lisette W A van Suijlekom-Smit
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

3.  Effect of Early and Prophylactic Nonsteroidal Anti-Inflammatory Drugs on Flare Duration in Pediatric Acute-Onset Neuropsychiatric Syndrome: An Observational Study of Patients Followed by an Academic Community-Based Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic.

Authors:  Kayla D Brown; Cristan Farmer; G Mark Freeman; Ellen J Spartz; Bahare Farhadian; Margo Thienemann; Jennifer Frankovich
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-11       Impact factor: 2.576

Review 4.  Biologics in children's autoimmune disorders: efficacy and safety.

Authors:  Luciana Breda; Marianna Del Torto; Sara De Sanctis; Francesco Chiarelli
Journal:  Eur J Pediatr       Date:  2010-06-17       Impact factor: 3.183

5.  Preventing tuberculosis in children receiving anti-TNF treatment.

Authors:  Nuray Aktay Ayaz; Erkan Demirkaya; Yelda Bilginer; Uğur Ozçelik; Nazan Cobanoğlu; Nural Kiper; Nesrin Besbas; Aysin Bakkaloğlu; Seza Ozen
Journal:  Clin Rheumatol       Date:  2010-04       Impact factor: 2.980

6.  Do patients with juvenile idiopathic arthritis in clinical remission have evidence of persistent inflammation on 3T magnetic resonance imaging?

Authors:  Amanda Brown; Raphael Hirsch; Tal Laor; Michael J Hannon; Marc C Levesque; Terence Starz; Kimberly Francis; C Kent Kwoh
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

7.  Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study.

Authors:  Alessandro Consolaro; Nicolino Ruperto; Giovanni Filocamo; Stefano Lanni; Giulia Bracciolini; Marco Garrone; Silvia Scala; Luca Villa; Giuseppe Silvestri; Daniela Tani; Alessandra Zolesi; Alberto Martini; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2012-11-20       Impact factor: 3.054

Review 8.  Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis.

Authors:  Kristen Hayward; Carol A Wallace
Journal:  Arthritis Res Ther       Date:  2009-02-23       Impact factor: 5.156

9.  The incidence of juvenile rheumatoid arthritis in Quebec: a population data-based study.

Authors:  Debbie Ehrmann Feldman; Sasha Bernatsky; Michelle Houde
Journal:  Pediatr Rheumatol Online J       Date:  2009-11-19       Impact factor: 3.054

10.  Juvenile idiopathic arthritis in Jordan: single center experience.

Authors:  Raed M Alzyoud; Motasem O Alsuweiti; Heba Q Almaaitah; Bushra N Aladaileh; Mohammad K Alnoubani; Adel M Alwahadneh
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-12       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.